PSORIASIS ARTHRITIS
Clinical trials for PSORIASIS ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS ARTHRITIS trials appear
Sign up with your email to follow new studies for PSORIASIS ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart shield? diabetes drug tested to fight artery damage in psoriatic arthritis
Disease control Not yet recruitingThis study tests whether semaglutide, a drug used for diabetes, can slow the buildup of plaque in arteries of people with psoriatic arthritis who do not have diabetes. About 40 participants will receive either semaglutide or standard care for 24 weeks. Researchers will measure ar…
Matched conditions: PSORIASIS ARTHRITIS
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated May 26, 2026 05:38 UTC
-
Costa rica psoriasis study: hidden heart and joint risks revealed
Knowledge-focused Not yet recruitingThis study will look at the health records of 350 people with psoriasis in Costa Rica to find out how common related conditions like obesity, diabetes, heart disease, and psoriatic arthritis are. Researchers will also see which treatments patients are using and how severe their p…
Matched conditions: PSORIASIS ARTHRITIS
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC
-
New study to reveal if earlier psoriatic arthritis treatments work better
Knowledge-focused Not yet recruitingThis study will follow 400 adults with psoriatic arthritis who are starting a new advanced therapy as part of their routine care. Researchers want to see if treatment works better when given earlier in the disease course, and whether measuring drug levels or antibodies in the blo…
Matched conditions: PSORIASIS ARTHRITIS
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 26, 2026 05:29 UTC
-
Costa rica launches registry to monitor psoriasis drugs in real life
Knowledge-focused Not yet recruitingThis study will follow 50 people in Costa Rica who are already taking IL-23 inhibitors (guselkumab or risankizumab) for psoriasis or psoriatic arthritis. Researchers will track how well the drugs improve skin and joint symptoms and quality of life, and note any side effects. The …
Matched conditions: PSORIASIS ARTHRITIS
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC